SWOG clinical trial number
SWOG-7806

Cis-Diamminedichloroplatinum (II) in the Treatment of Refractory Epidermoid Carcinoma of the Esophagus

Closed
Abbreviated Title
Cis-Diamminedichloroplatinum (II) in the Treatment of Refractory Epidermoid Carcinoma of the Esophagus
Activated
03/29/1978
Closed
01/29/1981

Publication Information Expand/Collapse

1984

Chemotherapy of advanced epidermoid carcinoma of the esophagus with single-agent cisplatin: Final report on a Southwest Oncology Group study.

FJ Panettiere;LP Leichman;EJ Tilchen;TT Chen Cancer Treat Rep 68:1023-1024

1981

Cis-diamminedichloride platinum (II), an effective agent in the treatment of epidermoid carcinoma of the esophagus. A preliminary report of an ongoing Southwest Oncology Group study.

FJ Panettiere;L Leichman;R O'Bryan;C Haas;W Fletcher Cancer Clin Trials 4:29-31

Cis-platinum (CACP) toxicity. An analysis based on 3 Southwest Oncology Group studies.

FJ Panettiere AACR, #623

Cis-platinum (CACP) toxicity. An analysis based on 3 Southwest Oncology Group studies.

FJ Panettiere AACR, #623

Cis-platinum (CACP) toxicity. An analysis based on 3 Southwest Oncology Group studies.

FJ Panettiere AACR, #623